Robatumumab

DB12976InvestigationalProtein Based Therapies

Robatumumab has been used in trials studying the treatment of Osteosarcoma, Sarcoma, Ewing's, and Peripheral Neuroectodermal Tumor.

Mechanism: Pharmacologically active on Insulin-like growth factor 1 receptor
Curator reviewed
Code names: Sch 717454

Resolves to

Compound

Targets

What you can answer from here — as of June 15, 2026

1Protein targetEach mapped to UniProt, with action and pharmacological action

Listed above

381Drug interactionsStructured to mechanism, not free text

4Clinical trialsPhase, status and sponsor resolved per trial

1+ReferenceStructured and connected to the statements they support

Which drugs share a target with Robatumumab, and which of those have an active Phase 3 trial?

Create a free account or log in to explore the full data card.